Abstract
Equine Herpesvirus-1 infection has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of: Article 7 on disease profile and impacts, Article 5 on the eligibility of the disease to be listed, Article 9 for the categorisation of the disease according to disease prevention and control measures as in Annex IV and Article 8 on the list of animal species related to Equine Herpesvirus-1 infection. The assessment has been performed following a methodology composed of information collection and compilation, and expert judgement on each criterion at individual and collective level. The outcome is the median of the probability ranges provided by the experts, which indicates whether the criterion is fulfilled (66–100%) or not (0–33%), or whether there is uncertainty about fulfilment (33–66%). For the questions where no consensus was reached, the different supporting views are reported. According to the assessment performed, Equine Herpesvirus-1 infection can be considered eligible to be listed for Union intervention according to Article 5 of the Animal Health Law with 33–90% certainty. According to the criteria as in Annex IV of the AHL related to Article 9 of the AHL for the categorisation of diseases according to the level of prevention and control, it was assessed with less than 1% certainty that EHV-1 fulfils the criteria as in Section 1 (category A), 1–5% for the criteria as in Section 2 (category B), 10–66% for the criteria as in Section 3 (category C), 66–90% for the criteria as in Section 4 (category D) and 33–90% for the criteria as in Section 5 (category E). The animal species to be listed for EHV-1 infection according to Article 8(3) criteria are the species belonging to the families of Equidae, Bovidae, Camelidae, Caviidae, Cervidae, Cricetidae, Felidae, Giraffidae, Leporidae, Muridae, Rhinocerontidae, Tapiridae and Ursidae.
| Original language | English |
|---|---|
| Article number | e07036 |
| Journal | EFSA Journal |
| Volume | 20 |
| Issue number | 1 |
| Online published | 12 Jan 2022 |
| DOIs | |
| Publication status | Published - Jan 2022 |
Bibliographical note
Research Unit(s) information for this publication is provided by the author(s) concerned.Funding
The cost of the establishment/running of a surveillance network for equine disease is significant. Such surveillance network involves a dedicated core team, the voluntary participation of sentinel equine practitioners (for reference, the RESPE involved around 800 sentinel veterinarians in France) and designated diagnostic laboratories. In the UK, the equine influenza surveillance programme was funded by the Horserace Betting Levy Board (HBLB, 2020). In 2019, the HBLB applied some £357,000 (around €415,000) for this operation alone and the same amount was announced for 2020 (HBLB, 2020). For reference, the HBLB has given £1.3 million (around €1.5 million) since 2013 for equine welfare research (surveillance operation excluded). Beyond staff and running charges, the cost of equine disease surveillance is primarily associated with the shipment of samples and diagnostic analyses. In France, the RESPE covers 50% of the diagnostic cost (cf. Section 69) for up to three cases on a premise. In the UK, equine influenza samples were covered at 100% by the surveillance network. The Department of Agriculture Food and the Marine contributes €250,000 annually to the running of the OIE reference laboratories for equine rhinopneumonia and equine influenza at the Irish Equine Centre. This assists with surveillance, testing during outbreaks nationally and internationally, virus typing and the supply of reference standards, diagnostic reagents and proficiency tests to MS and other OIE member countries (Cullinane, personal communication).
Research Keywords
- Animal Health Law
- categorisation
- Equidae
- Equine herpesvirus-1 infection
- horse
- impact
- listing
Publisher's Copyright Statement
- This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/
